The clinical treatment target for HbA1c in Denmark for type 1 diabetes is ≤53 mmol/mol [1]. 

The table below shows HbA1c outcomes by region [2]. The data demonstrates that only around 30% of patients with type 1 diabetes achieve the goals for HbA1c.